Sign in

CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202726770
Phone
862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. SC 13G/A Stake Amended Statement of Ownership
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations · Other events
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,131 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 4,133 shares (to pay taxes)
  16. 4 Shares withheld for taxes President and CEO gave up 15,689 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,709 shares (to pay taxes)
  18. 4 Grant or award Chief Business Officer acquired 5,030 shares (grant or award)
  19. 4 Shares withheld for taxes Chief Medical Officer gave up 2,709 shares (to pay taxes)
  20. 4 Shares withheld for taxes President and CEO gave up 11,697 shares (to pay taxes)

Page 10 of 74 · 1,467 filings